InvestorsHub Logo
Followers 1
Posts 131
Boards Moderated 0
Alias Born 09/12/2017

Re: Klinsmann post# 135

Tuesday, 11/27/2018 9:15:56 AM

Tuesday, November 27, 2018 9:15:56 AM

Post# of 278
Agree - several catalysts coming up very shortly - FDA meeting on re-submission of CarpX January 7, approval anytime to allow first-in-human CarpX clinical series in New Zealand in December, submission of EsoCheck CCD for 510(k) clearance by end of November, major investment bank exploring potential strategic partnerships including acquisition of PortIO. 2019 could be PAVM's year. Approval of CarpX and EsoCheck would, I think, result in SP being significantly higher next year. GL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PAVM News